Solvay adds polymer portfolio for single-use biopharmaceutical processing

Share

solvayFive new medical-grade polymers for biopharmaceutical manufacturing have recently been added to Solvay’s offerings.

Solvay hopes to support the industry’s shift toward single-use peripherals, filtration, bioreactors and containment by adding a new portfolio of polymers to its product family.

The company created its new biopharmaceutical manufacturing portfolio using five product families in its offerings including Radel polyphenylsulfone (PPSU), Udel polysulfone (PSU), AvaSpire polyaryletherketone (PAEK), KetaSpire polyetheretherketone (PEEK) and Ixef polyarylamide (PARA).

Solvay determined the effect of gamma irradiation up to 50 Key on each polymer family before determining what materials would be best for its portfolio. The company wanted to make sure each polymer family would be able to keep its mechanical performance and other application-critical properties. Solvay found that the polymers were compatible with gamma irradiation, which is the preferred sterilization method for single-use systems.

All polymers are also certified under U.S. Pharmacopeia (USP) Class VI test standards before and after sterilization.

DeviceTalks West: Expertise you need to know

textadimage Medical device suppliers are light years away from the days when they merely filled orders to spec for medtech OEMs – as a visit to the upcoming DeviceTalks West will quickly confirm.

From incorporating steerability into catheters to getting validation and testing done right, the companies serving the medical device industry have become specialized experts in their own right.

Read on to discover five example of medical device expertise to be had at DeviceTalks West, which runs Dec. 11–12 in Orange County, Calif.

Speak Your Mind

*